EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan

Takashige Abe iD, Kosuke Miyai, Toyonori Tsuzuki iD, Sachiyo Murai, Katsuyoshi Hashine iD, Shinichi Yamashita, Takashi Kawahara iD, Naotaka Nishiyama, Hiroshi Kitamura, Hiroshi Kikuchi iD, Kazutaka Saito, Hatsuki Hibi iD und 5 weitere

International Journal of Urology · 2026

DOI: 10.1111/iju.70399 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Urology, 2026. Verfasst von Takashige Abe und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Sex Cord-Gonadal Stromal Tumors, Testicular Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Sex cord‐stromal tumors (SCSTs) constitute approximately 5% of testicular malignancies. This investigation aimed to elucidate contemporary therapeutic approaches and clinical outcomes for patients with testicular SCSTs in Japan.

Methods

Participating institutions included Japan Clinical Oncology Group facilities, affiliated centers, and institutions with published cases. Clinical data and histopathological findings were compiled. Central pathological review involved representative tissue sections when available. Kaplan–Meier methodology assessed recurrence‐free survival (RFS) and overall survival (OS). Stage I patients were stratified by cumulative pathological risk factors (tumor diameter ≥ 5 cm, necrosis, moderate to severe nuclear atypia, lymphovascular invasion, infiltrative growth, and ≥ 3 mitoses per 10 high‐power fields).

Results

Among 116 patients from 66 institutions, 112 met inclusion criteria. Histological distribution included Leydig cell ( n = 54), Sertoli cell ( n = 36), and other variants ( n = 22). Twelve patients presented with metastatic disease; ten received systemic chemotherapy, with 20.8% five‐year OS. Among 91 stage I patients with follow‐up data, eleven developed recurrence. Patients with > 2 risk factors demonstrated significantly inferior RFS compared with those showing ≤ 1 factor (26.4 versus 98.6% at 5 years, p < 0.0001). Surgical intervention predominated in the recurrent cases (81.8%, 9/11), while chemotherapy was administered to 45.5% (5/11), and selected patients achieved prolonged disease control through repeated surgical resection without systemic therapy. OS rates were 90.9% and 50.5% at 5 and 10 years.

Conclusions

Patients with synchronous metastatic presentation demonstrated poor survival. Stage I patients with > 2 pathological risk factors showed reduced RFS, with surgical management potentially efficacious for recurrent disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sex Cord-Gonadal Stromal TumorsTesticular NeoplasmsHumansMaleJapanMiddle AgedAdultAgedYoung AdultTreatment OutcomeNeoplasm Recurrence, LocalRisk FactorsAdolescentNeoplasm StagingKaplan-Meier EstimateRetrospective StudiesDisease-Free Survival

Stichwörter der Autor:innen

pathological risk factorprognosissex cord stromal tumorsurvivaltreatment

Autor:innen und Institutionen

  • Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Department of Basic Pathology, National Defense Medical College, Saitama, Japan.
  • Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan.
  • Department of Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
  • Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.

ORCID-Profile: Takashige Abe, Toyonori Tsuzuki, Katsuyoshi Hashine, Takashi Kawahara, Hiroshi Kikuchi, Hatsuki Hibi, Takahiro Osawa

Zitieren

APA

Abe, T., Miyai, K., Tsuzuki, T., Murai, S., Hashine, K., Yamashita, S., Kawahara, T., Nishiyama, N., Kitamura, H., Kikuchi, H., Saito, K., Hibi, H., Miyata, H., Matsumoto, R., Osawa, T., Nishiyama, H., & Shinohara, N. (2026). Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan. International Journal of Urology. https://doi.org/10.1111/iju.70399

Vancouver

Abe T, Miyai K, Tsuzuki T, Murai S, Hashine K, Yamashita S, et al. Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan. International Journal of Urology. 2026. doi:10.1111/iju.70399

BibTeX
@article{Abe2026,
  author = {Abe, Takashige and Miyai, Kosuke and Tsuzuki, Toyonori and Murai, Sachiyo and Hashine, Katsuyoshi and Yamashita, Shinichi and Kawahara, Takashi and Nishiyama, Naotaka and Kitamura, Hiroshi and Kikuchi, Hiroshi and Saito, Kazutaka and Hibi, Hatsuki and Miyata, Haruka and Matsumoto, Ryuji and Osawa, Takahiro and Nishiyama, Hiroyuki and Shinohara, Nobuo},
  title = {Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan},
  journal = {International Journal of Urology},
  year = {2026},
  doi = {10.1111/iju.70399}
}
Kostenlos starten →